Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats
- PMID:16322268
- DOI: 10.1158/0008-5472.CAN-05-1945
Melatonin-depleted blood from premenopausal women exposed to light at night stimulates growth of human breast cancer xenografts in nude rats
Abstract
The increased breast cancer risk in female night shift workers has been postulated to result from the suppression of pineal melatonin production by exposure to light at night. Exposure of rats bearing rat hepatomas or human breast cancer xenografts to increasing intensities of white fluorescent light during each 12-hour dark phase (0-345 microW/cm2) resulted in a dose-dependent suppression of nocturnal melatonin blood levels and a stimulation of tumor growth and linoleic acid uptake/metabolism to the mitogenic molecule 13-hydroxyoctadecadienoic acid. Venous blood samples were collected from healthy, premenopausal female volunteers during either the daytime, nighttime, or nighttime following 90 minutes of ocular bright, white fluorescent light exposure at 580 microW/cm2 (i.e., 2,800 lx). Compared with tumors perfused with daytime-collected melatonin-deficient blood, human breast cancer xenografts and rat hepatomas perfused in situ, with nocturnal, physiologically melatonin-rich blood collected during the night, exhibited markedly suppressed proliferative activity and linoleic acid uptake/metabolism. Tumors perfused with melatonin-deficient blood collected following ocular exposure to light at night exhibited the daytime pattern of high tumor proliferative activity. These results are the first to show that the tumor growth response to exposure to light during darkness is intensity dependent and that the human nocturnal, circadian melatonin signal not only inhibits human breast cancer growth but that this effect is extinguished by short-term ocular exposure to bright, white light at night. These mechanistic studies are the first to provide a rational biological explanation for the increased breast cancer risk in female night shift workers.
Similar articles
- Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal.Xiang S, Dauchy RT, Hauch A, Mao L, Yuan L, Wren MA, Belancio VP, Mondal D, Frasch T, Blask DE, Hill SM.Xiang S, et al.J Pineal Res. 2015 Aug;59(1):60-9. doi: 10.1111/jpi.12239. Epub 2015 Apr 20.J Pineal Res. 2015.PMID:25857269Free PMC article.
- Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.Blask DE, Dauchy RT, Brainard GC, Hanifin JP.Blask DE, et al.Integr Cancer Ther. 2009 Dec;8(4):347-53. doi: 10.1177/1534735409352320.Integr Cancer Ther. 2009.PMID:20042410
- Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: impact of constant light-induced nocturnal melatonin suppression.Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC.Blask DE, et al.Breast Cancer Res Treat. 2003 Jun;79(3):313-20. doi: 10.1023/a:1024030518065.Breast Cancer Res Treat. 2003.PMID:12846415
- Light during darkness, melatonin suppression and cancer progression.Blask DE, Dauchy RT, Sauer LA, Krause JA, Brainard GC.Blask DE, et al.Neuro Endocrinol Lett. 2002 Jul;23 Suppl 2:52-6.Neuro Endocrinol Lett. 2002.PMID:12163849Review.
- Putting cancer to sleep at night: the neuroendocrine/circadian melatonin signal.Blask DE, Dauchy RT, Sauer LA.Blask DE, et al.Endocrine. 2005 Jul;27(2):179-88. doi: 10.1385/ENDO:27:2:179.Endocrine. 2005.PMID:16217131Review.
Cited by
- Brains in the city: Neurobiological effects of urbanization.Lambert KG, Nelson RJ, Jovanovic T, Cerdá M.Lambert KG, et al.Neurosci Biobehav Rev. 2015 Nov;58:107-22. doi: 10.1016/j.neubiorev.2015.04.007. Epub 2015 May 1.Neurosci Biobehav Rev. 2015.PMID:25936504Free PMC article.Review.
- Doxorubicin resistance in breast cancer is driven by light at night-induced disruption of the circadian melatonin signal.Xiang S, Dauchy RT, Hauch A, Mao L, Yuan L, Wren MA, Belancio VP, Mondal D, Frasch T, Blask DE, Hill SM.Xiang S, et al.J Pineal Res. 2015 Aug;59(1):60-9. doi: 10.1111/jpi.12239. Epub 2015 Apr 20.J Pineal Res. 2015.PMID:25857269Free PMC article.
- Urinary melatonin-sulfate/cortisol ratio and the presence of prostate cancer: A case-control study.Tai SY, Huang SP, Bao BY, Wu MT.Tai SY, et al.Sci Rep. 2016 Jul 8;6:29606. doi: 10.1038/srep29606.Sci Rep. 2016.PMID:27387675Free PMC article.
- A new apparatus and surgical technique for the dual perfusion of human tumor xenografts in situ in nude rats.Dauchy RT, Dauchy EM, Mao L, Belancio VP, Hill SM, Blask DE.Dauchy RT, et al.Comp Med. 2012 Apr;62(2):99-108.Comp Med. 2012.PMID:22546915Free PMC article.
- Melatonin: Countering Chaotic Time Cues.Arendt J.Arendt J.Front Endocrinol (Lausanne). 2019 Jul 16;10:391. doi: 10.3389/fendo.2019.00391. eCollection 2019.Front Endocrinol (Lausanne). 2019.PMID:31379733Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases